| abstract |
Disclosed is a matrix metalloproteinase 9 (MMP-9) inhibitor that is involved in the onset of cancer, rheumatoid arthritis, autoimmune disease, periodontitis, tissue ulceration, arteriosclerosis, aneurysm, heart failure, etc. Provided. MMP- comprising as an active ingredient a polysaccharide derived from cassis fruit, which is limited and partially decomposed and whose average molecular weight is in the range of 10,000 to 200,000. 9 Inhibitor. [Selection figure] None |